Banner of CND: United Nations Commission on Narcotic Drugs, policymaking body of the United Nations system with prime responsibility for drug-related matters
The resolutions and decisions database offers for full text search and sorting:
Promoting efforts by Member States to address and counter the world drug problem, in particular supply reduction-related measures, through effective partnerships with private sector entities
Promoting and improving the collection and analysis of reliable and comparable data to strengthen balanced, integrated, comprehensive, multidisciplinary and scientific evidence-based responses to the world drug problem
Promoting awareness-raising, education and training as part of a comprehensive approach to ensuring access to and the availability of internationally controlled substances for medical and scientific purposes and improving their rational use
Promoting the involvement of youth in drug prevention efforts
Promoting alternative development as a development-oriented drug control strategy
Inclusion of methyl alpha-phenylacetoacetate (MAPA), including its optical isomers, in Table I of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988
Inclusion of crotonylfentanyl in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol
Inclusion of valerylfentanyl in Schedule I of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol
Inclusion of DOC in Schedule I of the of the Convention on Psychotropic Substances of 1971
Inclusion of AB-FUBINACA in Schedule II of the Convention on Psychotropic Substances of 1971
Inclusion of 5F-AMB-PINACA (5F-AMB, 5F-MMB-PINACA) in Schedule II of the Convention on Psychotropic Substances of 1971
Inclusion of 5F-MDMB-PICA (5F-MDMB-2201) in Schedule II of the Convention on Psychotropic Substances of 1971
Inclusion of 4F-MDMB-BINACA in Schedule II of the Convention on Psychotropic Substances of 1971
Inclusion of 4-CMC (4-chloromethcathinone, clephedrone) in Schedule II of the Convention on Psychotropic Substances of 1971
Inclusion of N-ethylhexedrone in Schedule II of the Convention on Psychotropic Substances of 1971
Inclusion of alpha-PHP in Schedule II of the Convention on Psychotropic Substances of 1971
Inclusion of flualprazolam in Schedule IV of the Convention on Psychotropic Substances of 1971
Inclusion of etizolam in Schedule IV of the Convention on Psychotropic Substances of 1971
Changes in the scope of control of substances: proposed scheduling recommendations by the World Health Organization on cannabis and cannabis-related substances
Improved and streamlined annual report questionnaire
